Ajayi-Obe M, Saeed N, Cowan FM, Rutherford MA, Edwards AD.
2000. Reduced development of cerebral cortex in extremely preterm
infants. Lancet 356:1162–1163.
Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. 1998. Maturationdependent vulnerability of oligodendrocytes to oxidative stress-in- duced death caused by glutathione depletion. J Neurosci 18:6241– 6253.
Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC.
2001. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury.
J Neurosci 21:1302–1312.
Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, Arvin
KL, Holtzman DM. 2002a. Selective vulnerability of late oligodendrocyte
progenitors to hypoxia-ischemia. J Neurosci 22:455–463.
Back SA, Luo NL, Borenstein NS, Volpe JJ, Kinney HC. 2002b. Arrested
oligodendrocyte lineage progression during human cerebral white matter
development: dissociation between the timing of progenitor differentiation and myelinogenesis. J Neuropathol Exp Neurol 61:197–211.
Baud O, Greene AE, Li J, Wang H, Volpe JJ, Rosenberg PA. 2004a.
Glutathione peroxidase-catalase cooperativity is required for resistance
to hydrogen peroxide by mature rat oligodendrocytes. J Neurosci 24:
1531–1540.
Baud O, Li J, Zhang Y, Neve RL, Volpe JJ, Rosenberg PA. 2004b. Ni- tric oxide-induced cell death in developing oligodendrocytes is associated with mitochondrial dysfunction and apoptosis-inducing factor
translocation. Eur J Neurosci 20:1713–1726.
Bu ̈ hrer C, Atzpodien J, Oz S, Henze G. 1991. Fosfomycin does not
reduce cytostatic activity of cis-platinum against human osteosarcoma
cell lines in vitro. Pediatr Hematol Oncol 8:243–249.
Burke C, Gobe G. 2005. Pontosubicular apoptosis (``necrosis'') in human
neonates with intrauterine growth retardation and placental infarction.
Virchows Arch 446:640–645.
Collins MP, Lorenz JM, Jetton JR, Paneth N. 2001. Hypocapnia and
other ventilation-related risk factors for cerebral palsy in low birth
weight infants. Pediatr Res 50:712–719.
Dobbing J, Sands J. 1979. Comparative aspects of the brain growth spurt.
Early Hum Dev 3:79–83.
Felderhoff-Mueser U, Bittigau P, Sifringer M, Jarosz B, Korobowicz E,
Mahler L, Piening T, Moysich A, Grune T, Thor F, Heumann R,
Bu ̈ hrer C, Ikonomidou C. 2004. Oxygen causes cell death in the
developing brain. Neurobiol Dis 17:273–282.
Felderhoff-Mueser U, Sifringer M, Polley O, Dzietko M, Leineweber B,
Mahler L, Baier M, Bittigau P, Obladen M, Ikonomidou C, Bu ̈ hrer C.
2005. Caspase-1-processed interleukins in hyperoxia-induced cell death
in the developing brain. Ann Neurol 57:50–59.
Filomeni G, Rotilio G, Ciriolo MR. 2003. Glutathione disulfide induces
apoptosis in U937 cells by a redox-mediated p38 MAP kinase pathway.
FASEB J 17:64–66.
Gard AL, Pfeiffer SE. 1989. Oligodendrocyte progenitors isolated directly
from developing telencephalon at a specific phenotypic stage: myelinogenic potential in a defined environment. Development 106:119–132.
Gerstner B, Gratopp A, Marcinkowski M, Sifringer M, Obladen M,
Bu ̈ hrer C. 2005. Glutaric acid and its metabolites cause apoptosis in
immature oligodendrocytes: a novel mechanism of white matter degeneration in glutaryl-CoA dehydrogenase deficiency. Pediatr Res 57:771–
776.
Hack M, Flannery DJ, Schluchter M, Cartar L, Borawski E, Klein N.
2002. Outcomes in young adulthood for very-low-birth-weight infants.
N Engl J Med 346:149–157.
Halliwell B. 1992. Reactive oxygen species and the central nervous system. J Neurochem 59:1609–1623.
Hamrick SE, Miller SP, Leonard C, Glidden DV, Goldstein R, Ramaswamy V, Piecuch R, Ferriero DM. 2004. Trends in severe brain
injury and neurodevelopmental outcome in premature newborn infants:
the role of cystic periventricular leukomalacia. J Pediatr 145:593–599.
